Dr. Gregory Haljan is leading a clinical trial of a COVID-19 antibody. (Contributed photo)

Dr. Gregory Haljan is leading a clinical trial of a COVID-19 antibody. (Contributed photo)

B.C.-based clinical trial of COVID-19 antibody ‘very promising,’ says expert

Participation criteria expanded for infusion clinic based at Peace Arch Hospital

The clinical trial of a drug that one expert says looks “very promising” for use in stopping the progression of COVID-19 moved into a new phase this week, with the opportunity to participate now open to all eligible patients in the Fraser Health region.

Dr. Gregory Haljan – head of Surrey Memorial Hospital’s critical care unit and Fraser Health’s regional medical director for research – said Monday (April 26) that around 300 COVID-19-positive patients are sought to receive the medication bamlanivimab as part of the B-EPIC (Bamlanivimab-Emergency Passive Immunity in COVID-19) study.

READ MORE: Clinical trial of COVID-19 drug for severe cases to be carried out at Surrey hospital

Designed in January, the study aims to determine if the antibody can prevent those who get COVID-19 from getting so sick they need to be hospitalized – and if it can, “well, we really need that right now,” Haljan said.

“We’re in the third wave,” Haljan said of the pandemic. “This is the worst it’s been (in the SMH intensive care unit) yet. We’re working about as hard as we can right now in the ICU.

“This third wave has been a real kick in the pants.”

Researchers also want to learn if bamlanivimab can reduce the long-term effects of the illness.

Its use for COVID-19 treatment in high-risk patients has interim approval from Health Canada. The drug is designed to block the COVID-19 virus from attaching to and entering cells, thus potentially preventing the illness from worsening in newly diagnosed patients.

“Once you get an infection, it’s too late for a vaccine to work,” Haljan said. “What we want to do is provide those antibodies (that a vaccine typically triggers a body to produce) early in the disease, to give the immune system a head start.”

Recruiting for the study opened in March to residents of Surrey, White Rock and Delta. It then expanded to include patients living in Burnaby, Langley, Maple Ridge and Pitt Meadows.

Haljan said participants must begin the therapy within three days of a positive COVID-19 test, or within 10 days of their first symptoms.

Eligible participants are those 65 and older, or between 18 and 64 years old who have tested positive for COVID-19 and have at least one illness or condition that puts them at risk of being hospitalized for COVID-19 infection.

Haljan hopes to recruit up to 20 patients per day over the next two weeks, in order to complete the study by May 9.

Currently, the medication is being delivered at an infusion clinic set up at Peace Arch Hospital, but Haljan said the hope is to establish more clinics this week, particularly in the Fraser East area.

He emphasized that while the medication only has interim approval, it is “very safe,” and, it has been found to “retain activity” against the U.K variant of COVID-19; the most prevalent variant in Canada.

READ MORE: U.K variant of coronavirus detected at seven schools in Surrey, Delta

The study, he noted, “is asking questions nobody else in the world is asking right now about this drug.”

To sign up or for more information, visit www.bepicstudy.ca



tholmes@peacearchnews.com
Like us on Facebook and follow us on Twitter

CoronavirusSurreywhite rock

Just Posted

The District of 100 Mile House office. (File photo)
Tax rate for 100 Mile residents dips slightly

Average house assessment up, tax rate down

While the initial deadline for the 2021 Canadian Census has passed, there’s still time to complete it online or by mail. (Melissa Smalley photo - 100 Mile Free Press)
Census underway across country

Local workers distributing census package to rural areas

A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a COVID-19 vaccine clinic in Toronto on Thursday, January 7, 2021. THE CANADIAN PRESS/Nathan Denette
65 new cases of COVID-19 in Interior Health

Overall, B.C. is seeing a decrease in COVID-19 cases

Cariboo Chilcotin MLA Lorne Doerkson speaking in the legislature Monday, May 10. (Video screen shot)
Cariboo Chilcotin MLA calls for rural infrastructure renewal fund

Lorne Doerkson said central parts of rural B.C. devastated by flooding, crumbling infrastructure

FILE - In this April 19, 2021, file photo, Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. States across the country are dramatically scaling back their COVID-19 vaccine orders as interest in the shots wanes, putting the goal of herd immunity further out of reach. (AP Photo/Seth Wenig, File)
5 more deaths, 131 new cases of COVID-19 in Interior Health over the weekend

Those 18-years and older in high-transmission neighbourhoods can register for the vaccine

B.C. Labour Minister Harry Bains in the B.C. legislature, May 13, 2019. (Hansard TV)
VIDEO: B.C. to provide 3 days of sick pay for COVID-19 absences

Province will support employers on cost, labour minister says

Provincial health officer Dr. Bonnie Henry updates B.C.’s COVID-19 situation at the B.C. legislature, April 29, 2021. (B.C. government)
B.C.’s COVID-19 rate creeps up again, 600 new cases Wednesday

One more death, 423 people in hospital with virus

B.C. Agriculture Minister Lana Popham takes questions in the B.C. legislature in 2017. (Hansard TV)
UPDATE: B.C. will fund another year of fresh fruit, vegetables, milk in schools

John Horgan government working on school meal program

Surrey RCMP is releasing sketches of a suspect in an “indecent act” at the Coyote Creek Elementary playground on April 30, 2021. Police said the suspect was clean-shaven “during some interactions” and on “other occasions had stubble outlining a goatee and mustache.” (Images: Surrey RCMP handout)
Vancouver mayor-elect Kennedy Stewart addresses supporters in Vancouver on Sunday, Oct. 21, 2018. THE CANADIAN PRESS/Darryl Dyck
Vancouver mayor says there’s no time to redo details of drug decriminalization plan

Kennedy Stewart says a federal election could see the small window of opportunity close on the city’s bid for an exemption from criminal provisions on simple possession of small amounts of drugs

Premier Mike Horgan received his first dose of a COVID-19 vaccine. (Facebook/John Horgan)
More than 50% of people eligible in B.C. have received 1st vaccine dose

‘We’ve made extraordinary progress together over the past few weeks,’ says Premier Horgan

Brad MacKenzie, advocacy chair for the ALS Society of B.C., says having research projects in the province allows people here to have access to cutting-edge treatments now being developed. (B.C. government video)
B.C. funds research chair for Lou Gehrig’s disease at UBC

Pandemic has cut off patient access to international projects

In this Monday, March 15, 2021 file photo a vial of AstraZeneca vaccine is pictured in a pharmacy in Boulogne Billancourt, outside Paris. Questions remained Wednesday about the future of the Oxford-AstraZeneca vaccine in Canada, as Manitoba limited use of the shot and Ontario announced it planned to save an incoming shipment to use as second doses. THE CANADIAN PRESS/AP/Christophe Ena, File
Questions remain about the future of the Oxford-AstraZeneca shot in Canada

More than two million Canadians have received AstraZeneca and 17 have been confirmed to have VITT

Most Read